AMKR reports Q1 2026 results today having risen 27% in the past month, but a 4% pullback in the last session suggests some investors are taking profits ahead of the release.
The most striking feature of the setup is what the lending market is not saying. Short interest has fallen sharply — down more than 8% week-on-week to just under 3% of the free float — while borrow costs have eased to a near-frictionless 0.25%, down roughly 38% on the week. Availability remains ample. Taken together, the shorts have been retreating, not building, into a big move higher. Options positioning corroborates the lack of urgency: the put/call ratio at 0.94 is slightly below its 20-day average of 0.98, a roughly neutral reading that signals no unusual rush for downside protection ahead of the print. The ORTEX short score has also drifted lower through May, settling at 36.5 — well off highs seen in mid-April.
The analyst debate is overwhelmingly about degree, not direction. After the prior print in late April, Goldman Sachs raised its target from $43 to $65 while staying Neutral, and Morgan Stanley moved from $45 to $69 on an Equal-Weight rating — both meaningful upgrades in ambition with no change in conviction. Needham, the lone bull with a Buy, pushed its target to $90. No firm upgraded its rating outright. That pattern — higher numbers, unchanged enthusiasm — reflects broad agreement that Amkor's AI data-centre and advanced packaging exposure is real, while the bull-bear divide centres on execution risk. Bears flag the company's concentration in premium smartphone packaging and its exposure to foreign-currency swings as the primary vulnerabilities. Bulls point to the $7 billion Arizona facility and the company's CoWoS-R and CoWoS-L capabilities as proof that Amkor is not a passive beneficiary of the AI cycle but an active participant.
One ownership detail worth noting: the Kim family — founders and controlling shareholders — reduced their combined reported holdings meaningfully in the most recent period, including James Kim trimming by over 20 million shares. Three independent directors also sold in early May at prices in the $76–$77 range, above where the stock trades now. None of these sales carry an obvious distress signal, but the cluster just ahead of earnings is a data point the market will weigh against the stock's recent run.
The prior earnings event is a clear warning flag. The last Q1 print, on April 27, saw the stock fall roughly 8.6% in a single session and extend that to a 9.1% loss over five days — a reminder that even when the macro direction is right, Amkor's results can disappoint on the details. Today's print will test whether the 27% monthly rally has priced in execution the company still needs to prove.
See the live data behind this article on ORTEX.
Open AMKR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
